SCHEMBL455029

SCHEMBL455029

O=C(CCc1ccccc1)c1c(O)cc(O)cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC5A1 P13866 7/20 1.00
SLC5A2 P31639 7/20 1.00
GAA P10253 2/20 1.00
MAPT P10636 2/20 1.00
CYP19A1 P11511 4/20 0.77
NFKB1 P19838 2/20 0.77
NFKB2 Q00653 2/20 0.77
RELA Q04206 2/20 0.77
LMNA P02545 2/20 0.77
KDM4E B2RXH2 1/20 0.77
MEN1 O00255 1/20 0.77
SLC16A3 O15427 1/20 0.77
ALDH1A1 P00352 1/20 0.77
TTR P02766 1/20 0.77
ESR1 P03372 1/20 0.77
TP53 P04637 1/20 0.77
CYP1A2 P05177 1/20 0.77
POLB P06746 1/20 0.77
CYP3A4 P08684 1/20 0.77
CYP2D6 P10635 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phloretin SCHEMBL27817019 0.92 SLC5A1 (0.87) SLC5A1SLC5A2GAAMAPTCYP19A1
Phloretin SCHEMBL21192491 0.88 SLC5A1 (0.87) SLC5A1SLC5A2GAAMAPTCYP19A1
Phloretin SCHEMBL38131 0.87 SLC5A1 (1.00) SLC5A1SLC5A2GAAMAPTCYP19A1
Phloretin SCHEMBL1506325 0.87 SLC5A1 (1.00) SLC5A1SLC5A2GAAMAPTCYP19A1
SCHEMBL4742840 0.87 NFKB1 (0.80) SLC5A1SLC5A2GAAMAPTCYP19A1
SCHEMBL19668159 0.86 SLC5A1 (0.76) SLC5A1SLC5A2GAAMAPTCYP19A1
SCHEMBL30913242 0.86 SLC5A1 (0.76) SLC5A1SLC5A2GAAMAPTCYP19A1
Phloretin SCHEMBL30785809 0.86 SLC5A1 (0.96) SLC5A1SLC5A2GAAMAPTCYP19A1
Phloretin SCHEMBL30912872 0.86 SLC5A1 (0.96) SLC5A1SLC5A2GAAMAPTCYP19A1
Phloretin SCHEMBL31684375 0.86 SLC5A1 (0.96) SLC5A1SLC5A2GAAMAPTCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10695283-B2 Extract of Greyia radlkoferi and use thereof UNIVERSITY OF PRETORIA (ZA) 2020-06-30 US claimed
US-20180071204-A1 EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF UNIVERSITY OF KWAZULU-NATAL (ZA) 2018-03-15 US claimed
EP-2849768-B1 EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF UNIV PRETORIA (ZA) 2016-06-01 EP claimed
US-20150118337-A1 EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF UNIVERSITY OF PRETORIA (ZA) 2015-04-30 US claimed
US-20110256115-A1 HYDROSOLUBLE [6)O-ALPHA-D-GLCP-(1->]N-6-O-BETA-D-GLCP-(1->-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS LIBRAGEN (FR) 2011-10-20 US claimed
EP-2202237-A1 Hydrosoluble [6)-O-alpha-d-glcp-(1->]n-6-o-bêta-d-glcp-(1->-phenllic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds Libragen (FR) 2010-06-30 EP claimed
EP-4069659-B1 PINOCEMBRIN DIHYDROCHALCONE AND COMPOSITIONS THEREOF AND THEIR USE AS PESTICIDES METABOLIC INSIGHTS LTD (IL) 2025-11-05 EP disclosed
CN-120887861-A Acyl phloroglucinol derivative and preparation method and application thereof 暨南大学 2025-11-04 CN disclosed
CN-120554325-A Acyl phloroglucinol derivative and preparation method and application thereof 暨南大学 2025-08-29 CN disclosed
US-12382954-B2 Pinocembrin dihydrochalcone and compositions thereof and their use as pesticides METABOLIC INSIGHTS LTD. (IL) 2025-08-12 US disclosed
US-20250084049-A1 POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF FIRMENICH INCORPORATED (US) 2025-03-13 US disclosed
CN-118805781-A Pinocembrin dihydrochalcone and compositions thereof and their use as pesticides 代谢洞察有限公司 2024-10-22 CN disclosed
CN-114829320-B Pinocembrin dihydrochalcone and compositions thereof and their use as pesticides 代谢洞察有限公司 2024-07-19 CN disclosed
US-20130177515-A1 MONOTERPENE DERIVATIVES OF CHALCONE OR DIHYDROCHALCONE AND THEIR USE AS DEPIGMENTING AGENTS PIERRE FABRE DERMO-COSMETIQUE (FR) 2013-07-11 US disclosed
US-20130177515-A1 MONOTERPENE DERIVATIVES OF CHALCONE OR DIHYDROCHALCONE AND THEIR USE AS DEPIGMENTING AGENTS PIERRE FABRE DERMO-COSMETIQUE (FR) 2013-07-11 US disclosed
WO-2012033846-A1 ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2012-03-15 WO disclosed
EP-2379576-A1 HYDROSOLUBLE [6)-O-alpha-D-GLCP-(1->]n-6-O-beta-D-GLCP-(1->-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS Libragen (FR) 2011-10-26 EP disclosed
US-20110256115-A1 HYDROSOLUBLE [6)O-ALPHA-D-GLCP-(1->]N-6-O-BETA-D-GLCP-(1->-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS LIBRAGEN (FR) 2011-10-20 US disclosed
WO-2010072754-A1 HYDROSOLUBLE [6)O-α-D-GLCP-(1→]n-6-O-β-D-GLCP-(1→-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS LIBRAGEN (FR) 2010-07-01 WO disclosed
EP-2202237-A1 Hydrosoluble [6)-O-alpha-d-glcp-(1->]n-6-o-bêta-d-glcp-(1->-phenllic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds Libragen (FR) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110256115-A1 HYDROSOLUBLE [6)O-ALPHA-D-GLCP-(1->]N-6-O-BETA-D-GLCP-(1->-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS UGGT1, UGDH, CYP24A1 SLC5A1 240/4885SLC5A2 441/4885GAA 9/4885
US-20250084049-A1 POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF PGC, SLC5A6, PUF60 SLC5A1 207/4885SLC5A2 70/4885GAA 544/4885
US-20130177515-A1 MONOTERPENE DERIVATIVES OF CHALCONE OR DIHYDROCHALCONE AND THEIR USE AS DEPIGMENTING AGENTS CYP51A1, CDC42, MAP2 SLC5A1 4754/4885SLC5A2 4714/4885GAA 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.